List of Excipients in API doxazosin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxazosin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Viatris Specialty LLC | CARDURA | doxazosin | 58151-074 | CELLULOSE, MICROCRYSTALLINE | |
| Viatris Specialty LLC | CARDURA | doxazosin | 58151-074 | LACTOSE | |
| Viatris Specialty LLC | CARDURA | doxazosin | 58151-074 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxazosin
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 | CELLULOSE, MICROCRYSTALLINE |
| Major Pharmaceuticals | doxazosin | 0904-5522 | CROSCARMELLOSE SODIUM |
| Major Pharmaceuticals | doxazosin | 0904-5522 | LACTOSE MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for doxazosin
Excipient focus: ALUMINUM OXIDE
doxazosin drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
| DOH CENTRAL PHARMACY | doxazosin mesylate | 53808-1107 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
doxazosin drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxazosin mesylate | 0378-4021 |
| NCS HealthCare of KY Inc dba Vangard Labs | doxazosin mesylate | 0615-5536 |
| Upsher-Smith laboratories LLC | doxazosin mesylate | 0832-0356 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
doxazosin drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxazosin drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Method Pharmaceuticals LLC | doxazosin | 58657-822 |
| Roerig | doxazosin mesylate | 0049-2710 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doxazosin drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| AvKARE | doxazosin | 42291-258 |
| PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 30
doxazosin drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-647 |
| PD-Rx Pharmaceuticals Inc | doxazosin mesylate | 55289-022 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 67544-273 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
doxazosin drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
| State of Florida DOH Central Pharmacy | doxazosin mesylate | 53808-1017 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 71610-110 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
doxazosin drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | doxazosin | 50090-4000 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-831 |
| Aidarex Pharmaceuticals LLC | doxazosin mesylate | 33261-658 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
doxazosin drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | doxazosin | 50090-4000 |
| Method Pharmaceuticals LLC | doxazosin | 58657-822 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-831 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
doxazosin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | doxazosin mesylate | 29300-351 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
| State of Florida DOH Central Pharmacy | doxazosin mesylate | 53808-1017 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
doxazosin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | doxazosin | 50090-3927 |
| A-S Medication Solutions | doxazosin | 50090-3987 |
| NuCare Pharmaceuticals Inc | doxazosin | 68071-3811 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
doxazosin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| A-S Medication Solutions | doxazosin | 50090-5773 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
doxazosin drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doxazosin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
doxazosin drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | doxazosin | 58151-074 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-628 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-927 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
doxazosin drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | doxazosin | 58151-074 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-628 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-927 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
doxazosin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| A-S Medication Solutions | doxazosin | 50090-2153 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
doxazosin drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Method Pharmaceuticals LLC | doxazosin | 58657-822 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
doxazosin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
doxazosin drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doxazosin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Method Pharmaceuticals LLC | doxazosin | 58657-822 |
| Mylan Pharmaceuticals Inc | doxazosin mesylate | 0378-4021 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
doxazosin drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
doxazosin drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| AvKARE | doxazosin | 42291-258 |
| PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Aurobindo Pharma Limited | doxazosin mesylate | 59651-892 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | doxazosin | 16729-212 |
| Accord Healthcare Inc | doxazosin | 16729-414 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| AvKARE | doxazosin | 42291-258 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | doxazosin mesylate | 10544-629 |
| Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
| DOH CENTRAL PHARMACY | doxazosin mesylate | 53808-1107 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
doxazosin drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | doxazosin mesylate | 0093-2070 |
| Rebel Distributors Corp | doxazosin mesylate | 42254-075 |
| A-S Medication Solutions | doxazosin mesylate | 50090-3143 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doxazosin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Roerig | doxazosin mesylate | 0049-2710 |
| Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
| >Company | >Ingredient | >NDC |
doxazosin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | doxazosin | 0904-5522 |
| Rising Pharma Holdings Inc | doxazosin | 16571-165 |
| Accord Healthcare Inc | doxazosin | 16729-212 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
